On October 4, 2017, Mylan announced that two doses of their generic version of Copaxone® (glatiramer acetate) had been approved by the United States Food and Drug Administration (FDA) for […]
Read News ArticleAuthor: Hoff Communications
Spread the Word
Three books from MSAA’s free Lending Library are featured.
Read News ArticleThoughts about Giving: Swim for MS and other fundraising events are highlighted
Swim for MS and other fundraising events are highlighted.
Read News ArticleProgram Notes: New and Expanded Educational Programs Slated for this Fall
New and Expanded Educational Programs Slated for this Fall.
Read News ArticleResearch News: Recent study findings and new treatments are featured
Recent study findings and new treatments are featured.
Read News ArticleAsk the Doctor: Reducing Relapses in Secondary-Progressive MS
MSAA’s chief medical consultant answers questions sent in by readers.
Read News ArticleCover Story: Home and Lifestyle Modifications for Safety and Accessibility
Home and Lifestyle Modifications for Safety and Accessibility: Various strategies are presented for better living at home, from strategically placed grab bars for safety, to building ramps and widening doorways for increased accessibility.
Read News ArticleUp Front: You + MSAA = Helping People With MS
MSAA’s President and CEO expresses her thanks to our Board members and volunteers, while noting some of MSAA’s impactful programs and accomplishments.
Read News ArticleThe Motivator – Summer/Fall 2017
The Motivator: Summer/Fall 2017: MSAA’s 48-plus page magazine highlights and explains many vital issues of importance to our readers affected by MS.
Read News ArticleThank You – Navigating MS Interest Form
Thank you for your interest in Navigating MS. We have received your information and will contact you when new things are available.
Read News Article